Chemistry: molecular biology and microbiology – Vector – per se
Patent
1997-08-29
2000-04-25
Brusca, John S.
Chemistry: molecular biology and microbiology
Vector, per se
530350, 5303871, 536 235, 536 2372, C12N 1563, C12N 1533, C12N 1512, C07K 1400
Patent
active
060543124
ABSTRACT:
Filamentous phage particles displaying a ligand on their surface are used to deliver a therapeutic gene to a cell. The ligand is a fusion protein with a phage capsid protein, covalently conjugated to phage particles, or complexed with modified phage particles.
REFERENCES:
Georges et al. Synthesis of a human insulin gene VII. Synthesis of preproinsulin-like human DNA, its cloning and expression in M13 bacteriophage. Gene vol. 27 pp. 201-211, 1984.
Greenstein et al. Vectors derived from filamentous phages. In Current Protocols in Molecular Biology (Ausubel et al. Eds.) pp. 1.14.1-1.14.5 John Wiley & Sons, New York, 1993.
Orkin et al. Report and recommentations of the panel to assess the NIH investment in research on gene therapy. pp. 1-41, 1995.
Barry et al., "Toward cell-targeting gene therapy vectors: Selection of cell-binding peptides from random peptide-presenting phage libraries," Nature Medicine 2(3):299-305, 1996.
de Kruif et al., "Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library," Proc. Natl. Acad. Sci. USA 92:3938-3942, 1995.
Dunn, I.S., "Mammalian cell binding and transfection mediated by surface-modified bacteriophage lambda," Biochimie 78:856-861, 1996.
Hart et al., "Cell Binding and Internalization by Filamentous Phage Displaying a Cyclic Arg-Gly-Asp-containing Peptide," Journal of Biological Chemistry 269:12468-12474, 1994.
Ishiura et al., "Phage Particle-Medicated Gene Transfer to Cultured Mammalian Cells," Molecular and Cellular Biology 2(6):607-616, 1982.
Maruyama et al., ".lambda.foo: A .lambda. phage vector for the expression of foreign proteins," Proc. Natl. Acad. Sci. USA 91:8273-8277, 1994.
Okayama and Berg, "Bacteriophage Lambda Vector for Transducing a cDNA Clone Library into Mammalian Cells,"Molecular and Cellular Biology 5(5):1136-1142, 1985.
Pasqualini et al., ".alpha.v Integrins as receptors for tumor targeting by circulating ligands," Nature Biotechnology 15:542-546, 1997.
Pasqualini and Ruoslahti, "Organ targeting in vivo using phage display peptide libraries," Nature 380:364-366, 1996.
Russell, S. J., "Peptide-displaying phages for targeted gene delivery?" Nature Medicine 2(3):276-277, 1996.
Wu et al., "Development of a Novel Drug-Delivery System Using Bacteriophage MS2 Capsids, " Biochemical Society Transactions 24:413S, 1996.
Yokoyama-Kobayashi and Kato, "Recombinant f1 Phage Particles Can Transfect Monkey COS-7 Cells by DEAE Dextran Method", Biochemical and Biophysical Research Communications 192(2):935-939, 1993.
Yokoyama-Kobayashi and Kato, "Recombinant f1 Phage-Mediated Transfection of Mammalian Cells Using Lipopolyamine Technique," Analytical Biochemistry 223:130-134, 1994.
Hogrete et al., "Cloning in a bacteriophage lambda vector for the display of binding proteins on filamentous phage," Gene 137: 85091, 1993.
Hoogenboom et al., "Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) Heavy and light chains," Nucleic Acids Research 19(15): 4133-4137, 1991.
Jespers et al., "Surface Experssion and Ligand-Based Selection of cDNAs Fused to Filamentous Phage Gene VI," Bio/Technology 13: 378-382, 1995.
Rubenstein et al., "Subtractive hybridization system using single-stranded phagemids with directional inserts," Nucleic Acids Research 18(16): 4833-4842, 1990.
Soderlind et al., "Phage Display Technology in Antibody Engineering: Design of Phagemid Vectors and in vitroMaturation Systems," Immunological Reviews 130: 109-124, 1992.
Voiculescu, "Aspecte ale interrelatiilor bacteriofagi-celule cucariote," Bacteriologia, Virusologia, Parazitologia, Epidemiologia XXII(3): 141-148, 1977 (+ English Translation).
Baird Andrew
Johnson Wendy
Larocca David
Brusca John S.
Selective Genetics Inc.
LandOfFree
Receptor-mediated gene delivery using bacteriophage vectors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Receptor-mediated gene delivery using bacteriophage vectors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Receptor-mediated gene delivery using bacteriophage vectors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-992557